Is the EORTC QLQ-QNET21 Optimal for Patients with Neuroendocrine Tumors?

#2122

Introduction: Quality of life (QoL) is important to all cancer patients. The EORTC QLQ-QNET21 is the most commonly used questionnaire in patients with neuroendocrine tumors (NETs).

Aim(s): This study aims to evaluate patients’ attitudes towards this questionnaire.

Materials and methods: A cross-sectional qualitative pilot study. Participants with NETs from Colombia, France, Netherlands and Russia completed the EORTC QLQ-QNET21 scale followed by a novel questionnaire to assess whether this questionnaire is optimal.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: van Leeuwaarde R

Authors: Van Leeuwaarde R, Spada F, Cheung W, Gonzalez-Clavijo A, Pracht M,

Keywords: Quality of life, GEP-NET, EORTC QLQ-GINET21,